Oncologix Tech, Inc.
OCLG · OTC
11/30/2022 | 8/31/2022 | 11/30/2017 | 8/31/2017 | |
|---|---|---|---|---|
| Market Cap | $3 | $1 | $0 | $0 |
| - Cash | $0 | $0 | $0 | $0 |
| + Debt | $0 | $0 | $0 | $0 |
| Enterprise Value | $3 | $1 | $0 | $0 |
| Revenue | $0 | – | $1 | $1 |
| % Growth | – | – | -11.9% | – |
| Gross Profit | $0 | – | $0 | $0 |
| % Margin | – | – | 23.3% | 14.6% |
| EBITDA | -$0 | – | -$0 | -$1 |
| % Margin | – | – | -10% | -87.9% |
| Net Income | -$0 | – | -$0 | -$1 |
| % Margin | – | – | -37.3% | -184.4% |
| EPS Diluted | -0 | – | -0 | -0.002 |
| % Growth | – | – | 83.3% | – |
| Operating Cash Flow | -$0 | – | – | – |
| Capital Expenditures | $0 | – | – | – |
| Free Cash Flow | -$0 | – | – | – |